Breaking News
- 18 March 2011
- Utility of TIGRA assay for tuberculosis in patients with psoriasis on TNF-alpha inhibitor therapy
- 17 March 2011
- Autoantibodies against tyrosine hydroxylase higher patients with generalized vitiligo
- 16 March 2011
- Residual disease genomic profile of treated psoriasis lesions
- 15 March 2011
- Correlation of serum IL-22 and CCL17 levels in atopic dermatitis
- 14 March 2011
- Full-spectrum light phototherapy for atopic dermatitis
- 11 March 2011
- Aggravation of atopic dermatitis in breast-fed infants by various foods
- 10 March 2011
- Phase II study of sorafenib and pegylated interferon-alfa2b in advanced metastatic melanoma shows modest efficacy and serious adverse events
- 09 March 2011
- Homocysteine status and cardiovascular risk factors in psoriasis patients
- 08 March 2011
- Tacrolimus ointment is cost-effective as maintenance treatment in adult and pediatric atopic dermatitis
- 07 March 2011
- Population pharmacokinetics of ustekinumab in patients with active psoriatic arthritis
- 04 March 2011
- Topical heparin and levomenol combination reduces pruritus in atopic dermatitis
- 03 March 2011
- Differences in FCER1A N222K mutation between Japanese and Polish patients with atopic dermatitis
- 02 March 2011
- A novel biomarker identifies Bak as a candidate serum biomarker in melanoma
- 01 March 2011
- Comparison of drug survival rates for adalimumab, etanercept and infliximab in psoriasis patients
Last updated: 23 March 2011
AccessDermatology | © Copyright 2010 Prous Science S.A.U. a Thomson Reuters business or its licensors.
All rights reserved. Legal Information. Send your comments to Webmaster
ISSN 2013-8202
This site complies with the HONcode standard for trustworthy health information:
verify here.